Skip to content
COA & Batch Documentation Available Explore Research Peptides
Research Grade Independently Tested

GHK-Cu

Verified Synthesis Batch COA Available
≥ 99% (HPLC) CAS 89030-95-5 C₁₄H₂₂CuN₆O₄
$79.99 AUD · GST incl.
Select size
  • Certificate of Analysis available for every batch
  • Form: Lyophilised Powder
  • Storage: 2°C-8°C (Refrigerated)
  • Australia-wide, discreet tracked dispatch
  • Research Use Only - not for human or veterinary use

GHK-Cu peptide is one such copper binding peptide which has been extensively studied in laboratory research relating to tissue remodeling, extracellular matrix science, collagen formation, cellular signaling and skin science. Also called copper peptide GHK-Cu, the chemical has gained interest due to its role in copper transport and numerous signaling mechanisms.

GHK-Cu 50 mg and GHK-Cu 100 mg research chemicals allow researchers the ability to conduct laboratory studies in various material amounts. Current research examines the effects of the peptide on cellular repair, fibroblast function, collagen and elastin formation, antioxidation, inflammatory signaling and gene expression.

With an increasing interest in the study of GHK-Cu peptide in Australia, there is an increased interest in research material characterization in terms of identity, purity, documentation, traceability and storage conditions.

What Is GHK-Cu?

GHK-Cu is a natural copper compound that is produced through the interaction between the tripeptide glycyl-L-histidyl-L-lysine, known as GHK, and a copper ion.

The tripeptide has been found in human plasma and further studied in various biological liquids. The high binding capacity of GHK-Cu to copper plays a major role in scientific investigation since copper is related to multiple enzyme systems and biological processes.

Research involving GHK-Cu is usually associated with:

  • extracellular matrix remodelling;
  • studies of collagen and elastin;
  • fibroblast activity;
  • migration and signaling of cells;
  • models of wound healing;
  • antioxidant defense systems;
  • inflammatory signaling;
  • angiogenesis studies;
  • gene expression studies; and
  • dermatology and hair biology.

GHK-Cu should not be confused with regular copper supplements since it is a specific combination of a copper ion and a peptide which is the subject of scientific investigation.

Why Is GHK-Cu Being Studied?

Scientific interest in GHK-Cu peptide arises due to the possible involvement of the compound in biological signaling and copper transport.

The first research field is concerned with the biology of extracellular matrix. Studies in laboratory settings have looked at the interaction of GHK-Cu with structural proteins such as collagen and elastin. Scientists are interested in studying the role of peptide-mediated signaling in the functioning of fibroblasts and matrix metabolism and remodeling processes.

Tissue regeneration is another research topic for GHK-Cu. Studies in laboratory settings have been conducted on cellular migration, angiogenesis, inflammation and tissue remodeling in connection with the peptide.

The skin biology is another field of research for GHK-Cu. Research models have been used to investigate collagen metabolism, glycosaminoglycans, dermis structure and cellular reactions in connection with tissue aging.

Hair follicle research, oxidative stress, inflammation pathways and gene expression have also attracted scientific interest regarding GHK-Cu. However, research outcomes depend on the research model, dosage, formulation and design of study.

How Does GHK-Cu Work?

It is considered that the biological effects of GHK-Cu are produced by means of several interrelated mechanisms but not by one way only.

GHK peptide has the capacity to bind copper ions and can be involved in copper transportation and delivery process. Copper ions are cofactors of many enzymes necessary for biochemical processes, such as connective tissue biology, antioxidant defense and others.

There are several possible mechanisms of the action of GHK-Cu which were investigated by researchers:

Binding and transportation of copper ions: GHK binds copper ions forming a stable complex named GHK-Cu which is studied in the field of biochemical science.

Signalling in the extracellular matrix: The laboratory researches include its relation with collagen, elastin, proteoglycans and other elements of extracellular matrix.

Signalling in fibroblasts: Fibroblasts are responsible for the production and maintenance of the extracellular matrix components; GHK-Cu researches often study the signalling of these cells.

Pathways of oxidative stress: Experimental research includes the interaction of GHK-Cu with the pathways of oxidative damage and defense of organism.

Influence on gene expression: Some researches have been done in the field of gene expression in relation with GHK-Cu.

Understanding GHK-Cu Dosage

GHK-Cu dosage is frequently searched for online, however, it is necessary to distinguish between quantities used in laboratory experiments and medical doses.

GHK-Cu 50mg and GHK-Cu 100mg refer to the amount of the research material provided in one vial or product combination. These values do not indicate a medical dose or therapy regimen for humans.

Experimental concentration of GHK-Cu in laboratory studies may vary depending on:

  • a particular research model;
  • type of cells/tissue systems under study;
  • research goal;
  • experimental technique;
  • method of experimental administration;
  • choice of solvent; and
  • duration of exposure.

When conducting an experiment with GHK-Cu researchers have to follow the validated protocol, scientific methodology and institutional procedures.

GHK-Cu 50mg and GHK-Cu 100mg could fit various experimental protocols, however, the choice should be made based on a particular research protocol.

GHK-Cu and Research Quality

Product quality assessment is a factor that should be considered during peptide research. Only purity percentage does not give an accurate understanding of research material quality.

During evaluation of GHK-Cu peptide for laboratory study, the following factors may be considered by researchers:

Identification testing: Mass spectrometry or any other technique might assist in confirming the molecular identification.

Purity determination: High performance liquid chromatography (HPLC) is one of the common techniques for the determination of purity of the substance.

Traceability: Batch or lot number identification would assist in linking the product with its analytical data.

Certificate of Analysis: The available certificate of analysis should match the particular batch and provide analytical information.

Storage: Peptides can be influenced by temperature, humidity, light and multiple manipulations.

Documentation: The product specifications should include the information on the name of the substance, its quantity and proper storage conditions.

Australian researchers considering the purchase of GHK-Cu 50 mg or GHK-Cu 100 mg may benefit from clear information and documentation of the batches.

GHK-Cu in Australia

Research into GHK-Cu Australia has grown along with the general scientific interest in peptides, copper binding substances, regenerative sciences and skin science.

When Australian labs or researchers assess GHK-Cu peptide for research purposes, they need to take account of their planned research usage, documentation, batch numbers and storage needs. The product description must make clear whether the materials are for research purposes only and not approved medicinal items.

Peptides may have differing regulatory statuses depending upon the peptide, its use, claims, distribution route and other factors. Research institutes and companies need to be aware of current requirements concerning their situation before importing, distributing, possessing or using research materials.

GHK-Cu research products should be accurately represented and not marketed as replacements for medicines or professional medical advice.

What to Consider Before You Buy GHK-Cu

GHK-Cu peptide Australia research should involve factors other than just product quantity or cost.

Such considerations may include identification of the compound, analysis, traceability of batches, technical characteristics of the product, storage and availability of related documentation. For the comparison of GHK-Cu 50mg vs. GHK-Cu 100mg, it is necessary to choose quantities based on the protocol required for an experiment.

Prior to purchasing of research products, it is worth considering whether the provider can offer the following information: batch identification, availability of COA, package details and realistic description of the product from a research point of view.

Marketing statements about the guarantee of cosmetic, anti-ageing, hair growing and therapeutic effects should be viewed skeptically since results of experiments do not prove anything regarding approval or effectiveness for a certain use.

Safety and Current Research

The topic of GHK-Cu is currently under laboratory and experimental study. Topics of interest include extracellular matrix remodeling, collagen synthesis, cell signaling, oxidative stress, inflammation mechanisms, wound healing, and skin physiology.

Even though GHK occurs naturally, this does not imply that all preparations, dosages, or exposures to GHK-Cu have proven safe for individual use. Contamination and the preparation process may influence research results.

It is imperative for researchers to apply proper controls and procedures while undertaking their studies. Scientists must ensure they utilize contemporary scientific literature.

The materials applied during GHK-Cu research are not substitutes for FDA-approved medical therapies, and any findings derived from research must be interpreted in light of the experiment design.

Frequently Asked Questions

GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. It is studied in laboratory research involving copper transport, extracellular matrix biology, collagen synthesis and cellular signalling.

GHK refers to the tripeptide itself, while GHK-Cu refers to the complex formed when GHK binds a copper ion.

Researchers investigate GHK-Cu in areas including collagen and elastin biology, fibroblast activity, tissue remodelling, oxidative stress, inflammatory signalling, angiogenesis and gene expression.

These quantities indicate the amount of research material provided in the relevant product configuration. They are not recommended human dosages.

Experimental concentration should be based on the research model, published methodology, study design and validated laboratory protocol.

The names are closely associated and are commonly used in reference to the copper complex of glycyl-L-histidyl-L-lysine, although researchers should always verify the exact specification of the material being evaluated.

Common research areas include extracellular matrix biology, collagen synthesis, fibroblast signalling, skin biology, tissue remodelling, oxidative stress and gene expression.

Researchers should consider identity testing, chromatographic purity, batch traceability, COA documentation, storage information and consistency between the product specification and analytical records.

Regulatory status depends on the specific product, intended use, claims and supply circumstances. Current requirements should be checked with the relevant Australian regulatory authorities.

Key factors include material identity, batch traceability, analytical documentation, clear specifications, appropriate storage requirements and suitability for the intended laboratory research protocol.

Notice

GHK-Cu is an investigational peptide-copper complex intended for scientific research purposes. It should not be presented as an approved therapeutic medicine in Australia. Researchers and organisations should verify the current regulatory requirements applicable to their intended research, importation, possession and supply activities.

Disclaimer

This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning GHK-Cu includes preclinical research and ongoing or completed clinical investigations. Further research is required to better understand its safety, pharmacology and potential efficacy for specific research applications.

References

5 sources
  1. Pickart L, Vasquez-Soltero JM, Margolina A.
    The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health.
    Oxidative Medicine and Cellular Longevity. 2012;2012:324832.
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723/
  2. Pickart L, Vasquez-Soltero JM, Margolina A.
    GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.
    BioMed Research International. 2015;2015:648108.
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
  3. Pickart L, Margolina A.
    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
    International Journal of Molecular Sciences. 2018;19(7):1987.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/29986520/
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
  4. Pickart L.
    The Human Tri-Peptide GHK and Tissue Remodeling.
    Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/18644225/
  5. Australian Government, Therapeutic Goods Administration (TGA).
    Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products.
    Therapeutic Goods Administration. 19 June 2026.
    TGA: https://www.tga.gov.au/news/media-releases/concerns-regarding-public-health-risks-associated-unapproved-peptide-products
Medically & Scientifically Reviewed By

Dr. Priyanka Goel

Scientific & Medical Content Reviewer

Information last reviewed: 9 Jul 2026

The products and information offered by Verified Peptides are intended for legitimate laboratory, analytical and scientific research applications only. Products are not for human or veterinary use, and are not therapeutic goods. The results of studies should be interpreted based on the experimental model and the limitations of the existing evidence base.

Product information and educational materials are provided only for research and informational purposes and must not be interpreted as medical advice, diagnosis or treatment.

Added to cart
View Cart Checkout